Clinical Trial Update: Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated marimastat after chemotherapy in patients with small cell lung cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Marimastat (marimastat)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED